Mouth Ulcers Treatment Market

Mouth Ulcers Treatment Market (By Formulation - Mouthwash, Gel, Spray, Lozenge; By Indication - Aphthous Stomatitis, Oral Lichen Planus, Others; By Drug Class - Corticosteroid, Anesthetic, Analgesic, Antihistamine, Antimicrobial) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Global Mouth Ulcers Treatment Market: Snapshot

Mouth ulcers are non-critical and are formed due to oral injuries or wounds affecting the mucous membrane. Some of the factors resulting in the formation of mouth ulcers are stress, infection, injury, allergy, nutritional deficiencies, or genetic tendency, which further leads to intense pain. The inclination of consumers towards a healthy lifestyle is estimated to offer promising opportunities for the key players operating in the global mouth ulcer treatment market across the globe. The increasing level of competition and the emergence of innovative products are likely to encourage the growth of the global mouth ulcers market throughout the forecast period.

As per the research study, in 2013, the global market for mouth ulcer treatment was worth US$1,242.6 mn. The market is estimated to register a 3.80% CAGR between 2014 and 2020, reaching a value of US$1,596.9 mn by the end of 2020. Furthermore, technological advancements and innovations in the medicine field are expected to bolster global mouth ulcer treatment in the near future.

Growing Geriatric Population to Drive Demand for Mouth Ulcer Treatment

The increasing awareness about the serious condition of mouth ulcers and the availability of different treatments are estimated to fuel the growth of the global market in the next few years. In addition, the rising number of cases owing to the rising geriatric population and the lack of knowledge of maintaining mouth hygiene are expected to accelerate the growth of the mouth ulcers market across the globe. On the flip side, several side effects of mouth ulcer treatment such as head ache, blurred vision, and stomach pain are anticipated to curb the growth of the global market in the near future.

On the basis of formulation, the global mouth ulcers market has been classified into spray, gel, mouthwash, and lozenge. Among these, the gel segment is predicted to witness high growth in the coming few years. Furthermore, in terms of indication, aphthous stomatitis segment is expected to register a progressive growth rate in the near future. The drug classes in this global mouth ulcer treatment market are anesthetic, corticosteroid, analgesic, antimicrobial, and antihistamine.

Rising Prevalence Rate of Mouth Ulcers to Encourage Growth in North America 

From a geographical perspective, North America is anticipated to lead the global mouth ulcers market and is expected to remain in the topmost position throughout the forecast period. As per the study, this region is estimated to account for a key share of the market by the end of 2020, thanks to the growing awareness among consumers regarding the availability of effective mouth ulcer treatments. In addition, the increasing demand for mouth ulcer treatments owing to the rising prevalence rate is predicted to fuel the growth of the North America mouth ulcer treatment market in the coming few years.

Furthermore, Europe is anticipated to witness considerable growth in the coming years and remain in the second position in terms of revenue. The rising geriatric population in this region is one of the key factors anticipated to bolster mouth ulcers market in Europe. On the other hand, Asia Pacific is projected to register robust growth in the next few years, due to the favorable government initiatives and the rising number of mouth ulcer cases. The untapped opportunities in this region, especially in developing economies are predicted to supplement the growth of the market in the next few years.

Some of the prominent players operating in the global market for mouth ulcers treatment are Church & Dwight Co, Inc., ECR Pharmaceuticals, GlaxoSmithKline plc, 3M Healthcare, and Bristol Meyer Squibb Company.

    Chapter 1 Introduction
    1.1 Market Segmentation
    1.2 Research Methodology
          1.2.1 Secondary Research
          1.2.2 Primary Research
          1.2.3 Models
          1.2.4 Assumptions
    1.3 List of Abbreviations
     
    Chapter 2 Executive Summary
    2.2 Global Mouth Ulcers Treatment Market, by Drug Class, 2013 (USD Million)
    2.3 Comparative Analysis: Global Mouth Ulcers Treatment Market, by Geography, 2013 and 2020 (Value %)
     
    Chapter 3 Market Overview
    3.1 Overview
    3.2 Market Drivers
          3.2.1 Increasing awareness about mouth ulcers primarily accentuates the market growth
          3.2.2 Aging population propels the demand for mouth ulcers treatment products
    3.3 Market Restraints
          3.3.1 Side effects pose threat to the growth of this market
    3.4 Market Opportunities
          3.4.1 Asia Pacific holds immense growth potential in mouth ulcers treatment
    3.5 Value Chain Analysis
    3.6 Porter’s Five Forces Analysis: Global Mouth Ulcers Treatment Market
          3.6.1 Bargaining power of suppliers
          3.6.2 Bargaining power of buyers
          3.6.3 Threat of new entrants
          3.6.4 Threat of Substitutes
          3.6.5 Competitive Rivalry
    3.7 Market Attractiveness Analysis: Global Mouth Ulcers Treatment Market, by Geography
    3.8 Heat Map Analysis for Key Market Players
          3.8.1 Heat Map Analysis of the Mouth Ulcers Treatment Market, by Key Market Players, 2013
                   3.8.1.1 3M Health Care
                   3.8.1.2 Taro Pharmaceutical Industries Ltd.
     
    Chapter 4 Mouth Ulcers Treatment Market, by Drug Class
    4.1 Overview
          4.1.1 Global Mouth Ulcer Treatments Market Revenue, by Formulation, 2012 - 2020 (USD Million)
    4.2 Mouthwash
          4.2.1 Global Mouthwashes Market Revenue, 2012 - 2020 (USD Million)
    4.3 Gels
          4.3.1 Global Gels Market Revenue, 2012 - 2020 (USD Million)
    4.4 Sprays
          4.4.1 Global Sprays Market Revenue, 2012 - 2020 (USD Million)
    4.5 Lozenges
          4.5.1 Global Lozenges Market Revenue, 2012 - 2020 (USD Million)
     
    Chapter 5 Mouth Ulcer Treatment Market, by Indication
    5.1 Overview
          5.1.1 Global Mouth Ulcer Treatments Market Revenue, by Indication, 2012 - 2020 (USD Million)
    5.2 Aphthous Stomatitis
          5.2.1 Global Aphthous Stomatitis Market Revenue, 2012 - 2020 (USD Million)
    5.3 Oral Lichen Planus
          5.3.1 Global Oral Lichen Planus Market Revenue, 2012 - 2020 (USD Million)
    5.4 Others
          5.4.1 Global Others Market Revenue, 2012 - 2020 (USD Million)
     
    Chapter 6 Mouth Ulcers Treatment Market, by Drug Class
    6.1 Overview
          6.1.1 Global Mouth Ulcer Treatments Market Revenue, by Drug Class, 2012 - 2020 (USD Million)
    6.2 Corticosteroids
          6.2.1 Global Corticosteroid Market Revenue, 2012 - 2020 (USD Million)
    6.3 Anesthetics
          6.3.1 Global Anesthetic Market Revenue, 2012 - 2020 (USD Million)
    6.4 Analgesics
          6.4.1 Global Analgesic Market Revenue, 2012 - 2020 (USD Million)
    6.5 Antihistamines
          6.5.1 Global Antihistamine Market Revenue, 2012 - 2020 (USD Million)
    6.6 Antimicrobials
          6.6.1 Global Antimicrobial Market Revenue, 2012 - 2020 (USD Million)
     
    Chapter 7 Mouth Ulcers Treatment Market, by Geography
    7.1 Overview
          7.1.1 Global Mouth Ulcers Treatment Market Revenue, by Geography, 2012 – 2020 (USD Million)
    7.2 North America
          7.2.1 North America Mouth Ulcers treatment Market Revenue, 2012 – 2020 (USD Million)
    7.3 Europe
          7.3.1 Europe Mouth Ulcers treatment Market Revenue, 2012 – 2020 (USD Million)
    7.4 Asia-Pacific
          7.4.1 Asia-Pacific Mouth Ulcers treatment Market Revenue, 2012 – 2020 (USD Million)
    7.5 Rest of the World
          7.5.1 RoW Mouth Ulcers treatment Market Revenue, 2012 – 2020 (USD Million)
     
    Chapter 8 Recommendations
    8.1 Market Strategy for Success
          8.1.1 Investing in emerging markets to gain market share
          8.1.2 Mergers and acquisitions for sufficient market expansion
          8.1.3 Develop innovative product that ensures less side effect
     
    Chapter 9 Company Profiles
    9.1 3M
          9.1.1 Company overview
          9.1.2 Financial overview
          9.1.3 Product Portfolio
          9.1.4 Business Strategies
          9.1.7 Recent Developments
    9.2 BLISTEX, INC.
          9.2.1 Company Overview
          9.2.2 Financial Overview
          9.2.3 Product Portfolio
    9.3 Bristol-Myers Squibb Company
          9.3.1 Company Overview
          9.3.2 Financial Overview
          9.3.3 Product Portfolio
          9.3.4 Business Strategies
          9.3.5 Recent Developments
    9.4 Church & Dwight Co., Inc.
          9.4.1 Company Overview
          9.4.2 Financial Overview
          9.4.3 Product Portfolio
          9.4.4 Business Strategies
          9.4.6 Recent Developments
    9.5 The Colgate-Palmolive Company
          9.5.1 Company Overview
          9.5.2 Financial Overview
          9.5.3 Product Portfolio
          9.5.4 Business Strategies
          9.5.6 Recent Developments
    9.6 ECR Pharmaceuticals
          9.6.1 Company Overview
          9.6.2 Financial Overview
          9.6.3 Product Portfolio
          9.6.4 Recent Developments
    9.7 GlaxoSmithKline plc
          9.7.1 Company Overview
          9.7.2 Financial Overview
          9.7.3 Product Portfolio
          9.7.4 Business Strategies
          9.7.7 Recent Developments
    9.8 Pfizer, Inc.
          9.8.1 Company Overview
          9.8.2 Financial Overview
          9.8.3 Product Portfolio
          9.8.4 Business Strategies
          9.8.7 Recent Developments
    9.9 Taro Pharmaceutical Industries Ltd.
          9.9.1 Company Overview
          9.9.2 Financial Overview
          9.9.3 Product Portfolio      
          9.9.4 Business Strategies
          9.9.6 Recent Developments
    List of Tables
     
    TABLE 1 List of Abbreviations
    TABLE 2 Market Snapshot: Global Mouth Ulcers Treatment Market (2013 & 2020)
    TABLE 3 Global Mouth Ulcer Treatments Market Revenue, by Formulation, 2012 - 2020 (USD Million)
    TABLE 4 Global Mouth Ulcer Treatments Market Revenue, by Indication, 2012 - 2020 (USD Million)
    TABLE 5 Global Mouth Ulcer Treatments Market Revenue, by Drug Class, 2012 - 2020 (USD Million)
    TABLE 6 Global Mouth Ulcers Treatment Market Revenue, by Geography, 2012 – 2020 (USD Million)

    List of Figures

     

    FIG. 1 Mouth Ulcers Treatment : Market Segmentation

    FIG. 2 Global Mouth Ulcers Treatment Market, by Drug Class, 2013 (USD Million)

    FIG. 3 Comparative Analysis: Global Mouth Ulcers Treatment Market, by Geography, 2013 & 2020 (Value %)

    FIG. 4 Porter’s Five Forces Analysis: Global Mouth Ulcers Treatment Market

    FIG. 6 Market Attractiveness Analysis: Global Mouth Ulcers Treatment Market, by Geography, 2013 Value (%)

    FIG. 7 Heat Map Analysis of Key Market Players of the Mouth Ulcers Treatment Market

    FIG. 7 Global Mouthwashes Market Revenue, 2012 - 2020 (USD Million)

    FIG. 8 Global Gels Market Revenue, 2012 - 2020 (USD Million)

    FIG. 9 Global Sprays Market Revenue, 2012 - 2020 (USD Million)

    FIG. 10 Global Lozenges Market Revenue, 2012 - 2020 (USD Million)

    FIG. 11 Global Aphthous Stomatitis Market Revenue, 2012 - 2020 (USD Million)

    FIG. 12 Global Oral Lichen Planus Market Revenue, 2012 - 2020 (USD Million)

    FIG. 13 Global Others Market Revenue, 2012 - 2020 (USD Million)

    FIG. 14 Global Corticosteroid Market Revenue, 2012 - 2020 (USD Million)

    FIG. 15 Global Anesthetic Market Revenue, 2012 - 2020 (USD Million)

    FIG. 16 Global Analgesic Market Revenue, 2012 - 2020 (USD Million)

    FIG. 17 Global Antihistamine Market Revenue, 2012 - 2020 (USD Million)

    FIG. 18 Global Antimicrobial Market Revenue, 2012 - 2020 (USD Million)

    FIG. 19 North America Mouth Ulcers Treatment Market Revenue, 2012 – 2020 (USD Million)

    FIG. 20 Europe Mouth Ulcers Treatment Market Revenue, 2012 – 2020 (USD Million)

    FIG. 21 Asia-Pacific Mouth Ulcers Treatment Market Revenue, 2012 – 2020 (USD Million)

    FIG. 22 RoW Mouth Ulcers Treatment Market Revenue, 2012 – 2020 (USD Million)

    FIG. 23 Annual Revenue: 3M, 2011 – 2013 (USD Million)*

    FIG. 24 Bristol-Myers Squibb Company: Annual Revenue, 2011 – 2013 (USD Million)

    FIG. 25 Church & Dwight Co., Inc.: Net Sales, 2011 – 2013 (USD Million)

    FIG. 26 Colgate-Palmolive Company: Net Sales, 2011/12 – 2013/14 (USD Million)

    FIG. 27 GlaxoSmithKline plc: Annual Sales, 2011 – 2013 (USD Million)

    FIG. 28 Pfizer, Inc.: Annual Revenue, 2011 – 2013 (USD Million)

    FIG. 29 Taro Pharmaceutical Industries Ltd: Net Sales, 2011 – 2013 (USD Million)

Copyright © Transparency Market Research, Inc. All Rights reserved